We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04409145
Recruitment Status : Terminated (Part 1 complete; Part 2 will not be completed.)
First Posted : June 1, 2020
Last Update Posted : August 4, 2022
Information provided by (Responsible Party):
Venthera, Inc., a BridgeBio company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 13, 2022
Actual Study Completion Date : April 13, 2022